Small Molecules

Traditional pharma manufacturers are already dipping their toes in the waters of continuous processing, but what about when it comes to biopharmaceuticals?

Our experience with implementing serialization, has shown us that anti-counterfeiting is just one of its potential uses.

Antibody drug conjugates offer a great deal of potential for drug targeting, but what’s the best way of linking drugs and antibodies?

Where did Quality by Design come from? Where will it lead to in pharma? And is there a day when the concept will no longer exist?

Can the stress of space force fungi to produce novel therapeutics?

Sitting Down With... Ann Hayes, Owner, The Ann Hayes Consultancy, Stevenage, UK.

Hot Melt Extrusion helps to enable pharmaceutical companies to literally solve their solubilization issue.

Researchers working to gain greater knowledge into crystallization believe that functionalized glass can trigger nucleation of specific crystals.

The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.

The first switch from batch to continuous manufacturing has been made – and approved by the FDA. Will pharma’s future be continuous?